Guggenheim Securities
Overview
Guggenheim Securities is the investment banking and capital markets business of Guggenheim Partners. We are a full-service, independent investment bank with a history of thought leadership, an expansive network of relationships, and a focus on superior execution to achieve optimal outcomes for our clients.
Portfolio Companies
53
Website
guggenheimsecurities.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Fervo Energy | Apr 2026 | IPO | Co-investor |
| Generate Biomedicines | Feb 2026 | IPO | Co-investor |
| TierPoint | Oct 2025 | Debt | Lead |
| MBX Biosciences | Sep 2025 | Follow-on Offering | Lead |
| Amylyx Pharmaceuticals | Sep 2025 | Follow-on Offering | Lead |
Key People
Abishek Senthilkumaran
Managing Director
Adam Ruda
Managing Director
Aneeket Shah
Managing Director
Brent Surber
Senior Managing Director
Chris Macios
Senior Managing Director
Cliff Crain
Managing Director
Colin LaForge
Managing Director
David Blais
Senior Managing Director
David Dahlson
Managing Director
Debjit Chattopadhyay
Senior Managing Director
Derek Ahmann
Senior Managing Director
Dino Dedić
Senior Managing Director
Dru Rushing
Senior Managing Director
Enrico DeMatt
Managing Director
Evan Mueller
Managing Director
James Schaefer
Senior Managing Director
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
